Lawrence Panasci MD
Professor, Medicine & Oncology Gertrude & Stanley Vineberg Clinician Scientist Chair, Breast Cancer Committee,

Department of Oncology McGill University & Associate Director,

Department of Oncology Jewish General Hospital

MAILING ADDRESS
Jewish General Hospital
Oncology Centre, E-175
3755 Cote Ste Catherine
Montreal, Quebec H3T 1E2

ACADEMIC BACKGROUND

Degree	Year	Discipline/Field Institution and Country
B.Sc.	1968	Mathematics Georgetown University (Magna Cum Laude)
MD	1972	Medicine Georgetown University Medical School
Internship	1972-1973	Medicine Case Western Reserve University Medical School, Affiliated Program, Cleveland Ohio
Residency	1973-1974	Medicine Case Western Reserve University Medical School, Affiliated Program, Cleveland Ohio
Residency	1974-1975	Medicine Georgetown Division, D.C. General Hospital, Washington D.C.
Research Fellow	1975-1977	Oncology Division of Medical Oncology, Georgetown University Hospital, Washington D.C.
Clinical Fellow	1976-1977	American Cancer Society
Visiting Fellow	1977	Instituto Nazionale Tumori, Milan Italy
Attending Physician	1978-1980	Internal Medicine and Medical Oncology Syracuse University

AREAS OF EXPERTISE

Position Held	Institution/Organization	Department/Faculty	Period
Assistant Professor	Upstate Medical Center and Veterans Administration Medical Center, Syracuse NY	Medicine	1978
Assistant Professor	McGill University, Jewish General Hospital	Medicine	1980-1984
Associate Professor	McGill University	Medicine	1985-1991
Associate Director	Oncology Department, Jewish General Hospital	Oncology	1989-present
Associate Professor	Geographic Full Time-University Joint	Oncology	1991-1998
Professor	McGill University	Medicine and Oncology	1998-present

RESEARCH SUPPORT

Principal Applicant	Title of Project	Funding Source and Program	Years of Tenure
L. Panasci	Mechanism of increased cytotoxicity of SarCNU in gliomas	NIH US	1994-1997
L. Panasci	Nitrogen Mustard Drug Resistance in Chronic Lymphocytic Leukemia: Implications for therapy	Cancer Research Society	1995-1999
L. Panasci	Determination of nucleotide excision gene protein levels in the NCI tumor cell line panel	United States National Cancer Institute Contract	1997
L. Panasci	Phase I trial of SarCNU	NIH US	1998-2000
L. Panasci	Modulation of DNA-PK activity to alter chlorambucil drug resistance in chronic lymphocytic leukemia	The Leukemia and Lymphoma Society	1998-2001
L. Panasci	Assessment of P-40 expression levels in tissue samples and correlation with resistance to chemotherapy	Aurelium Biopharma Contract	2000-2001